A prospective, multicentric, randomized, double-blind, parallel, phase IV study to assess the safety and efficacy of TycamzziTM (sovateltide) in patients with acute cerebral ischemic stroke - Nil
A multicenter, randomized, double-blind, placebo -controlled, phase-II trial to assess safety, and efficacy of sovateltide in the treatment of hypoxic-ischemic encephalopathy in neonates
A prospective, multi-centric, open-labeled, phase-IV study to assess safety and efficacy of LYFAQUIN™ (Centhaquine citrate) as a resuscitative agent for hypovolemic shock to be used as an adjuvant to standard treatment of shock.
100 项与 Pharmazz India Pvt Ltd. 相关的临床结果
0 项与 Pharmazz India Pvt Ltd. 相关的专利(医药)
100 项与 Pharmazz India Pvt Ltd. 相关的药物交易
100 项与 Pharmazz India Pvt Ltd. 相关的转化医学